PROVIDENCE — U.S. Rep. David R. Obey, chairman of the House
Appropriations Committee, toured four major research institutions in
the city’s Jewelry District on Friday along with Rep. Patrick J.
Kennedy, Mayor David N. Cicilline, Governor Carcieri and other state leaders.
The
group of about 30 city and state officials and local entrepreneurs
visited Lifespan’s Coro Center, Brown University’s Laboratories for
Molecular Medicine, the biomedical firm EpiVax and the Kilguss Research
Institute of Women & Infants Hospital.
The purpose of the
tour was to show Obey, a Wisconsin Democrat, what federal investment
has done to help grow Rhode Island’s research and science institutions
and to stress the need for increased federal funding in the life
sciences for the state’s economic future, according to Kennedy, who is
also a member of the appropriations committee, which oversees the
federal budget.
Rhode Island, which suffers from one of the
highest unemployment rates in the nation, at 13 percent, has made the
city’s Jewelry District a pillar of its economic-development plan.
State
leaders hope that turning the former center of costume-jewelry
manufacturing into a hub of biotech, life science and “knowledge-based”
industries — similar to Boston’s Route 128 corridor or North Carolina’s
Research Triangle — will help resolve many of the state’s chronic
shortcomings, from its difficulty in attracting major companies and
creating new industries, to retaining college students after graduation
and providing job opportunities for low-skilled residents.
City
hospitals, universities and other major nonprofit institutions have
already committed major investments in the neighborhood.
Brown
University, for example, envisions a new downtown campus centered along
Richmond Street in the Jewelry District to be anchored by its Warren
Alpert Medical School, which is expected to open in 2011.
Acres
of land will open up in the next two years as the old Route 195 is
demolished, presenting an opportunity for additional expansion of
research labs, office and residential space.
Kennedy and others
contended on Friday that an essential part of the vision is increased
federal funding to build on existing research development and
investment in the district.
“The merits are here,” Kennedy said.
“But the political case needs to be made … We have got to make the case
to the White House that we deserve federal support.”
Cicilline
said federal investment is crucial to the city’s efforts to accelerate
development and become a leader in the “global knowledge economy.”
Obey,
following the two-hour tour, seemed supportive of the state’s vision.
The district is a “solid engine for growth,” he said. “This is a good
investment for Rhode Island. We need to be doing dozens of these in the
U.S. as a whole.”
The tour started at the Coro Center, off Point
Street, where the group learned how federal funding is helping
scientists advance stem cell research.
Just a few blocks away,
at Brown University’s Laboratories for Molecular Medicine, on Ship
Street, they observed a demonstration of the university’s x-ray
crystallographer, which helps scientists determine the arrangement of
atoms within a crystal and learned about a $26-million federal grant
for the university’s Superfund Research Program, which studies
contaminated industrial sites in Rhode Island.
At an office
building on Clifford Street, Dr. Annie S. DeGroot explained how her
11-year-old firm, EpiVax, is carving a niche in infectious and
autoimmune disease research, including the development of a possible
AIDS vaccine.
The tour ended at the Kilguss Research Institute of
Women & Infants Hospital, where researchers, funded by the National
Institutes of Health, are studying heart and lung development in
fetuses and babies. (Obey and Kennedy also visited Thundermist Health
Center in Woonsocket later in the day.)
At each place,
researchers emphasized the value of being located within a growing
cluster of research institutions and laboratories, and being within
walking distance of most of the city’s six hospitals.
“It’s a
really collaborative environment in the Jewelry District,” said Dr.
James F. Padbury, pediatrician-in-chief at Women & Infants. “We
share use of high-end machines. We write grants together … It’s a
really fun environment.”
DeGroot, chief executive officer of
EpiVax, said she came to the district three years ago from a location
elsewhere in the city. “I said, ‘This is it. This is where I want to
be,’ ” she said. “We’re definitely here to stay.”
Researchers also spoke about the work they hope to accomplish with federal funds they’ve recently applied for.
Padbury,
of Kilguss, said that Brown and the University of Rhode Island have
applied for a $20-million grant from the National Institutes of Health
to build a new Center for Clinical and Translational Sciences, which
would research ways to improve patient care.
And Dr. Wolfgang
Peti, of the Brown Molecular Medicine labs, said that Brown hopes to
become a regional center for bio-macromolecular research, which is the
study of protein molecules such as DNA and RNA.
In May, his team
applied for an $8-million grant from NIH to purchase a new nuclear
magnetic-resonance spectrometer, a machine that helps scientists
analyze protein structure. Weighing four tons and standing nearly two
stories tall, the machine would be larger than anything available in
the region, if not the country, Peti said.
Such a powerful tool
could help Brown scientists delve more into neurological research such
as Parkinson’s disease and cancer research, and attract researchers
from throughout New England to use the machine for other studies.
01:00 AM EST on Saturday, November 14, 2009